JACOBS LEVY EQUITY MANAGEMENT, INC - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,038,000
-65.8%
200,808
-83.0%
0.02%
-65.2%
Q2 2022$8,878,000
-10.6%
1,183,676
+8.5%
0.07%
+3.0%
Q1 2022$9,931,000
+39.4%
1,091,297
+7.6%
0.07%
+39.6%
Q4 2021$7,122,000
+3.3%
1,014,556
+67.8%
0.05%
+4.3%
Q3 2021$6,893,000
-25.5%
604,639
+4.6%
0.05%
-27.0%
Q2 2021$9,251,000
+158.6%
577,832
+188.6%
0.06%
+125.0%
Q1 2021$3,578,000
-51.2%
200,228
-63.1%
0.03%
-56.2%
Q4 2020$7,325,000
+312.7%
542,175
+259.6%
0.06%
+255.6%
Q3 2020$1,775,000150,7900.02%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders